United States · FDA National Drug Code directory
Enoxaparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0548-5606_2910408b-d506-4a3a-a2c8-64fc46ba0da0
- Product NDC
- 0548-5606
- Form
- INJECTION
- Composition / generic term
- Enoxaparin sodium
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110919
- Source listing expiry
- 20261231
Source-listed ingredients
- ENOXAPARIN SODIUM — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (0548-5606-00) / .8 mL in 1 SYRINGE · 0548-5606-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →